Peloton Therapeutics Secures $18,000,000 Series A Funding
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b2d5a471-ff55-4f81-8d0d-44c63b70d9cc&Preview=1 - Date
7/27/2011 - Company Name
Peloton Therapeutics - Mailing Address
2330 Inwood Road Dallas, TX 75235 - Company Description
Working in close collaboration with scientists at UT Southwestern, Peloton is advancing a promising discovery and development pipeline, comprised of several small molecule-based programs, each with a distinct target and mechanism of action. Peloton’s vision is to become a major biotech company in Dallas with a passion for discovering and developing novel cancer drugs. - Website
http://www.pelotontherapeutics.com - Transaction Type
Venture Equity - Transaction Amount
$18,000,000 - Transaction Round
Series A - Proceeds Purposes
Peloton officials said the company will focus initially on advancing several well differentiated oncology programs, each of which has already yielded promising lead compounds with novel mechanisms of action. - M&A Terms
- Venture Investor
The Column Group - Venture Investor
Undisclosed
